GlassScriptPhysician profile
Allison T Brown
NPI 1821309428
$598.24
in general payments reported to CMS, 2019-2025
9 companies · $69.92 in 2025
The $69.92 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $206 · 2023: $223 · 2024: $100 · 2025: $69.92.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $393.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $392.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $216.66 | 2022-2024 | Azstarys, Azstarys |
| Abbott Laboratories | $106.26 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $77.81 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $69.92 | 2025 | Jardiance |
| Phadia US INC. | $36.30 | 2023-2024 | Immunocap |
| Tris Pharma INC | $31.31 | 2023 | Dyanavel Xr |
| Ascendis Pharma Endocrinology INC | $23.57 | 2024 | |
| Biomarin Pharmaceutical INC. | $20.26 | 2024 | Voxzogo 1.2mg |
| Boston Scientific Corporation | $16.15 | 2024 | Watchman Flx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.